incretin hormone glp-1 hormones and the satiation signal GLP-1 is released from the

In clinical trials, once-weekly semaglutide at diabetes doses (0.51 mg) produces mean weight loss of 46 kg (913 lbs), while the 2.4 mg dose (Wegovy) achieves average weight reductions of 1215% of body weight

Because GLP-1 medications require regular subcutaneous injection, reliable and patient-friendly delivery systems are critical for successful therapy adoption

When you lose weight fast, your body produces less collagen

It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM

The use of GLP-1RAs reduced independent nicotine use and nicotine cravings in animals, weight gain after nicotine cessation, cravings for it, abstinence and hyperphagia [84]